Skip to content

Clinical trials

Completed Phase 3 Hyperphosphatemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphosphatemia Phase: Phase 3 Status: Completed Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20064
20074
20081
20092
20107
20111
20122
20134
20151
20161
20171
20182
20193
20214
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc5
Tanabe Pharma Corporation5
Bayer4
Kissei Pharmaceutical Co., Ltd.4
Kyowa Kirin Co., Ltd.4
Keryx Biopharmaceuticals3
Ardelyx2
Genzyme, a Sanofi Company2
Panion & BF Biotech Inc.2
Alebund Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphosphatemia41
Renal Insufficiency, Chronic20
Renal Insufficiency11
Kidney Failure, Chronic9
Kidney Diseases3
Anemia, Iron-Deficiency2
Phosphorus Metabolism Disorders2
Bronchiolitis Obliterans Syndrome1
Chronic Kidney Disease-Mineral and Bone Disorder1
Disease Progression1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.